The University of Chicago Header Logo

Connection

Larry Goldstein to Ischemic Attack, Transient

Back to Details
This is a "connection" page, showing publications Larry Goldstein has written about Ischemic Attack, Transient.
Larry Goldstein
Connection Strength
5.592
Ischemic Attack, Transient
  1. Letter by El Husseini et al regarding article, "What causes disability after transient ischemic attack and minor stroke?". Stroke. 2012 Dec; 43(12):e180.
    View in: PubMed
    Score: 0.391
  2. Concerns for the reliability and validity of the National Stroke Project Stroke Severity Scale. Cerebrovasc Dis. 2011; 32(5):426-30.
    View in: PubMed
    Score: 0.362
  3. Echocardiography for the detection of cardiac sources of embolism in patients with stroke or transient ischemic attack. J Stroke Cerebrovasc Dis. 2012 Oct; 21(7):577-82.
    View in: PubMed
    Score: 0.347
  4. Stroke: Organizing the disorganized: improving TIA patient care. Nat Rev Neurol. 2011 Apr; 7(4):190-2.
    View in: PubMed
    Score: 0.346
  5. Exploration of a hypothesized independent association of a common 9p21.3 gene variant and ischemic stroke in patients with and without angiographic coronary artery disease. Cerebrovasc Dis. 2011; 31(2):117-22.
    View in: PubMed
    Score: 0.340
  6. Elderly women have lower rates of stroke, cardiovascular events, and mortality after hospitalization for transient ischemic attack. Stroke. 2009 Jun; 40(6):2116-22.
    View in: PubMed
    Score: 0.301
  7. Non-atherosclerotic vascular disease in the young. J Thromb Thrombolysis. 2005 Oct; 20(2):93-103.
    View in: PubMed
    Score: 0.238
  8. Is this patient having a stroke? JAMA. 2005 May 18; 293(19):2391-402.
    View in: PubMed
    Score: 0.232
  9. Cardiovascular Risk Factor Profiles, Emergency Department Visits, and Hospitalizations for Women and Men with a History of Stroke or Transient Ischemic Attack: A Cross-Sectional Study. J Womens Health (Larchmt). 2022 06; 31(6):834-841.
    View in: PubMed
    Score: 0.185
  10. Advances in Stroke: Treatments-Preventive. Stroke. 2022 02; 53(2):608-610.
    View in: PubMed
    Score: 0.184
  11. New transient ischemic attack and stroke: outpatient management by primary care physicians. Arch Intern Med. 2000 Oct 23; 160(19):2941-6.
    View in: PubMed
    Score: 0.169
  12. Reply: Hemorrhagic Stroke, All-Cause Death, and Intensive LDL-C Lowering: Evidence From SPARCL and Beyond. J Am Coll Cardiol. 2020 08 18; 76(7):886-888.
    View in: PubMed
    Score: 0.167
  13. Atorvastatin Reduces First and Subsequent Vascular Events Across Vascular Territories: The SPARCL Trial. J Am Coll Cardiol. 2020 05 05; 75(17):2110-2118.
    View in: PubMed
    Score: 0.162
  14. Association of Osteopontin, Neopterin, and Myeloperoxidase With Stroke Risk in Patients With Prior Stroke or Transient Ischemic Attacks: Results of an Analysis of 13 Biomarkers From the Stroke Prevention by Aggressive Reduction in Cholesterol Levels Trial. Stroke. 2017 12; 48(12):3223-3231.
    View in: PubMed
    Score: 0.138
  15. Statins and the Risk of Intracerebral Hemorrhage in Patients With Previous Ischemic Stroke or Transient Ischemic Attack. Stroke. 2017 12; 48(12):3245-3251.
    View in: PubMed
    Score: 0.138
  16. Accuracy of ICD-9-CM Codes by Hospital Characteristics and Stroke Severity: Paul Coverdell National Acute Stroke Program. J Am Heart Assoc. 2016 05 31; 5(6).
    View in: PubMed
    Score: 0.125
  17. US National Survey of Physician Practices for the Secondary and Tertiary Prevention of Ischemic Stroke. Carotid endarterectomy. Stroke. 1996 May; 27(5):801-6.
    View in: PubMed
    Score: 0.124
  18. Effect of high-dose atorvastatin on renal function in subjects with stroke or transient ischemic attack in the SPARCL trial. Stroke. 2014 Oct; 45(10):2974-82.
    View in: PubMed
    Score: 0.110
  19. Multicenter review of preoperative risk factors for carotid endarterectomy in patients with ipsilateral symptoms. Stroke. 1994 Jun; 25(6):1116-21.
    View in: PubMed
    Score: 0.109
  20. Atherogenic dyslipidemia and residual cardiovascular risk in statin-treated patients. Stroke. 2014 May; 45(5):1429-36.
    View in: PubMed
    Score: 0.108
  21. Death and rehospitalization after transient ischemic attack or acute ischemic stroke: one-year outcomes from the adherence evaluation of acute ischemic stroke-longitudinal registry. J Stroke Cerebrovasc Dis. 2013 Oct; 22(7):e181-8.
    View in: PubMed
    Score: 0.098
  22. Regional variation in recommended treatments for ischemic stroke and TIA: Get with the Guidelines--Stroke 2003-2010. Stroke. 2012 Jul; 43(7):1858-64.
    View in: PubMed
    Score: 0.094
  23. Depression and antidepressant use after stroke and transient ischemic attack. Stroke. 2012 Jun; 43(6):1609-16.
    View in: PubMed
    Score: 0.093
  24. Risk of stroke and cardiovascular events after ischemic stroke or transient ischemic attack in patients with type 2 diabetes or metabolic syndrome: secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Arch Neurol. 2011 Oct; 68(10):1245-51.
    View in: PubMed
    Score: 0.088
  25. Recurrent transient ischemic attacks and stroke in association with an internal carotid artery web. Stroke. 1991 Jan; 22(1):94-8.
    View in: PubMed
    Score: 0.086
  26. Coronary heart disease risk in patients with stroke or transient ischemic attack and no known coronary heart disease: findings from the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke. 2010 Mar; 41(3):426-30.
    View in: PubMed
    Score: 0.080
  27. Lack of impact of paramedic training and use of the cincinnati prehospital stroke scale on stroke patient identification and on-scene time. Stroke. 2009 Mar; 40(3):754-6.
    View in: PubMed
    Score: 0.075
  28. Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Atherosclerosis. 2009 Jun; 204(2):515-20.
    View in: PubMed
    Score: 0.073
  29. Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack. Neurology. 2009 Feb 24; 72(8):688-94.
    View in: PubMed
    Score: 0.073
  30. Effects of intense low-density lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack: the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke. 2007 Dec; 38(12):3198-204.
    View in: PubMed
    Score: 0.069
  31. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006 08 10; 355(6):549-59.
    View in: PubMed
    Score: 0.063
  32. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Circulation. 2006 Mar 14; 113(10):e409-49.
    View in: PubMed
    Score: 0.061
  33. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke. 2006 Feb; 37(2):577-617.
    View in: PubMed
    Score: 0.061
  34. Prevention and health services delivery. Stroke. 2005 Feb; 36(2):222-4.
    View in: PubMed
    Score: 0.057
  35. Statin use and stroke outcomes in the Heart and Estrogen-Progestin Replacement Study (HERS). Neurology. 2004 Mar 23; 62(6):968-70.
    View in: PubMed
    Score: 0.054
  36. Preventing ischemic stroke in patients with prior stroke and transient ischemic attack : a statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke. 1999 Sep; 30(9):1991-4.
    View in: PubMed
    Score: 0.039
  37. Primary care physician-reported secondary and tertiary stroke prevention practices. A comparison between the United States and the United Kingdom. Stroke. 1997 Apr; 28(4):746-51.
    View in: PubMed
    Score: 0.033
  38. The rational clinical examination. Clinical assessment of stroke. JAMA. 1994 Apr 13; 271(14):1114-20.
    View in: PubMed
    Score: 0.027
  39. Prediction of major vascular events after stroke: the stroke prevention by aggressive reduction in cholesterol levels trial. J Stroke Cerebrovasc Dis. 2014 Apr; 23(4):778-84.
    View in: PubMed
    Score: 0.027
  40. Relative and cumulative effects of lipid and blood pressure control in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels trial. Stroke. 2009 Jul; 40(7):2486-92.
    View in: PubMed
    Score: 0.019
  41. Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke. 2008 Dec; 39(12):3297-302.
    View in: PubMed
    Score: 0.018
  42. Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke. 2008 May; 39(5):1647-52.
    View in: PubMed
    Score: 0.018
  43. Health status of individuals with mild stroke. Stroke. 1997 Apr; 28(4):740-5.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.